India's Biotech Startups Enter Uncharted Territories

India’s Biotech Startups Enter Uncharted Territories

India’s biotechnology startup ecosystem is entering an exciting new era — moving beyond traditional pharmaceutical manufacturing and contract research into cutting-edge areas including genomics, personalised medicine, synthetic biology, gene therapy, and digital health. Indian biotech startups are increasingly competing on the global stage, attracting international investment and partnerships.

Key Trends Driving India’s Biotech Innovation

• Genomics and personalised medicine — the falling cost of DNA sequencing and growing awareness of genetic health risks are driving demand for personalised genomic testing and precision medicine solutions

• Diagnostics innovation — COVID-19 accelerated the development of rapid, affordable diagnostic technologies; Indian startups are now applying these capabilities to a broader range of diseases

• Digital health integration — combining genomic data with wearables, electronic health records, and AI-driven analytics for holistic, personalised health insights

• Global partnerships — Indian biotech startups are increasingly partnering with international research institutions, hospitals, and technology companies to scale their innovations globally

MapmyGenome: Pioneering Genomics in India

MapmyGenome has been at the forefront of India’s genomics revolution since 2013 — building India’s largest personal genomics platform, India’s largest proprietary Indian genetic database (GenomegaDB), and a CAP & NABL-accredited laboratory that has analysed thousands of samples from across India and various countries.